Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aldosterone Antagonism in Diastolic Heart Failure
NCT00108251Phase 4Completed
- Sponsor
- United States Department of Veterans Affairs
- Start
- Aug 2004
- Primary completion
- Sep 2007
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in heart failure with preserved ejection fraction (HFpEF) comparing Placebo with Eplerenone (2 arms). Primary endpoint: Six Minute Walk Distance at 24 weeks. Started Aug 2004; status: completed.
02
Drugs
eplerenone
03
Conditions
heart failure with preserved ejection fraction (HFpEF)
Beyond the preview
Go deeper on NCT00108251.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00108251.